Related Experiment Video
Updated: Jun 9, 2026

Detection of Aggregation-Prone Behavior in Mutant P53 V157F Breast Cancer Cells Using Multipoint Thioflavin T Fluorescence
Published on: December 30, 2025
Dysregulated KIF2A correlates with p53 expression pattern in breast cancer
Yun Hao1, Si-Qin Ma2, Ting Xu3
1Department of Breast Surgery, General Surgery, Qilu Hospital of Shandong University, Jinan, 250012, China.
Abstract:
Kinesin family member 2A (KIF2A) and p53 play crucial roles in tumor development and progression. However, their correlation in breast cancer remains unclear. Immunohistochemistry (IHC) was performed on 357 breast cancer specimens to investigate the expression status of KIF2A and p53, their correlations with clinicopathological parameters and prognosis, and their interrelationship in breast cancer. The results demonstrated that KIF2A was highly expressed in breast cancer tissues and exhibited two subcellular localization patterns: nuclear-enriched and cytoplasmic-enriched localization. High KIF2A expression was associated with the human epidermal growth factor receptor 2 (HER2)-positive subtype, lymph node metastasis (LNM), high Ki67 index, and advanced TNM stage, whereas cytoplasmic-enriched localization was associated with higher tumor grade. Both high KIF2A expression and cytoplasmic-enriched localization predicted poor prognosis in patients with breast cancer. A composite index integrating KIF2A expression and localization was an independent prognostic factor. p53 IHC analysis revealed expression pattern categorized as wild-type (57.7%), overexpression (20.4%), and null pattern (21.8%). Abnormal p53 expression (overexpression and null pattern) was associated with LNM, advanced N-stage, high histological grade, estrogen receptor-negative status, progesterone receptor-negative status, HER2-positive status, high Ki67 index, and triple-negative molecular subtypes. Patients with the wild-type, null, and overexpression pattern demonstrated progressively worse prognosis. Additionally, the combined status of KIF2A and p53 IHC could effectively stratify the prognosis of breast cancer. Finally, KIF2A expression was found to be higher in patients with abnormal p53 expression. This study revealed the expression interplay and clinical significance of KIF2A and p53 in breast cancer. The identified association between KIF2A and p53 may provide insights for future research on their roles in breast cancer.
Related Concept Videos
Abnormal Proliferation
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Negative Regulator Molecules
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...